Page last updated: 2024-11-05

urapidil and Aging

urapidil has been researched along with Aging in 5 studies

Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.

Research Excerpts

ExcerptRelevanceReference
"Urapidil, an antihypertensive agent with dual action (alpha 1-adrenergic antagonist and 5HT1A agonist) is well established in the treatment of arterial hypertension."4.79Review of studies with urapidil in elderly hypertensives. ( Hansson, L; Petitet, A, 1995)
"Urapidil is a selective alpha 1-adrenoceptor antagonist with central antihypertensive action which is increasingly used in the treatment of hypertension."4.77Clinical pharmacokinetics of urapidil. ( Haerlin, R; Kirsten, R; Nelson, K; Steinijans, VW; Zech, K, 1988)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leposavić, G1
Pešić, V1
Stojić-Vukanić, Z1
Radojević, K1
Arsenović-Ranin, N1
Kosec, D1
Perišić, M1
Pilipović, I1
Hansson, L1
Petitet, A1
Buñag, RD1
Thomas, CV1
Mellick, JR1
Kirsten, R1
Nelson, K1
Steinijans, VW1
Zech, K1
Haerlin, R1

Reviews

2 reviews available for urapidil and Aging

ArticleYear
Review of studies with urapidil in elderly hypertensives.
    Blood pressure. Supplement, 1995, Volume: 3

    Topics: Aging; Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Piperazines

1995
Clinical pharmacokinetics of urapidil.
    Clinical pharmacokinetics, 1988, Volume: 14, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aging; Digoxin; Drug Interactions; Half-Life; Humans; Hypertension;

1988

Other Studies

3 other studies available for urapidil and Aging

ArticleYear
Age-associated plasticity of α1-adrenoceptor-mediated tuning of T-cell development.
    Experimental gerontology, 2010, Volume: 45, Issue:12

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aging; Animals; Apoptosis; CD4-Positive T-Lymphocytes; CD8-

2010
Adaptation of antihypertensive drug treatment with increasing age: from the young to the elderly. Focus on urapidil.
    Blood pressure. Supplement, 1995, Volume: 3

    Topics: Adult; Aged; Aging; Antihypertensive Agents; Humans; Hypertension; Middle Aged; Piperazines

1995
Ketanserin versus urapidil: age-related cardiovascular effects in conscious rats.
    European journal of pharmacology, 2002, Jan-18, Volume: 435, Issue:1

    Topics: Aging; Angiotensins; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Bradycardia; Keta

2002